Overview

Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Status:
Recruiting

Trial end date:
2021-10-01

Target enrollment:

Participant gender:

Summary

Researchers conduct the clinical trial (gemcitabine combined with cisplatin induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine for locally advanced nasopharyngeal carcinoma) to evaluate the safety and effectiveness of gemcitabine in patients with locally advanced nasopharyngeal carcinoma.

Phase:

Phase 1

Details

Lead Sponsor:

Fifth Affiliated Hospital, Sun Yat-Sen University

Treatments:

Gemcitabine